 Molecular diagnostics company Genetic Technologies Limited ASX: GTG; NASDAQ: GENE, Company, provides the following update to the market. Breast Cancer and Colorectal Cancer tests commissioned, and sales commenced First Quarter 2020 with over 100 test kits distributed. 